Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap | Zendy

Yong Suk Jo | Zendy; Sung Ok Kwon | Zendy; Jee-Young Kim | Zendy; Woo Jin Kim | Zendy

Open Access

Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap

Author(s) -

Yong Suk Jo,

Sung Ok Kwon,

Jee-Young Kim,

Woo Jin Kim

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.07.86

Subject(s) - medicine , asthma , biomarker , lipocalin , pulmonary disease , disease , neutrophil gelatinase associated lipocalin , gelatinase , intensive care medicine , immunology , matrix metalloproteinase , biochemistry , chemistry

There is no standardized definition of the asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO). Although the blood eosinophil count is regarded as a biomarker for identifying ACO, it has no distinct value. This study aimed to measure plasma levels of neutrophil gelatinase-associated lipocalin (NGAL), a potential biomarker for distinguishing between ACO and non-ACO COPD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research